Furthermore, loss of PTEN function concurrently increased the expression of CXCL8 receptors (CXCR1 and CXCR2), with the resulting elevated autocrine CXCL8 signaling acting to sustain the viability of these PTEN-deficient prostate cancer cells [20]. Here, PTEN is linked to prostate carcinoma.